Back to Trades
Hardy Alexander
Chief Executive OfficerDirectorCIK 0002001910
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Hardy Alexander, Chief Executive Officer, Director, has disclosed $6.5M in transactions — all concentrated in BIOMARIN PHARMACEUTICAL INC (BMRN). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Mar 19 | BMRN BIOMARIN PHARMACEUTICAL INC | Hardy Alexander | Chief Executive Officer, Director | Tax withheld | $238.3K |
| Mar 17 | BMRN BIOMARIN PHARMACEUTICAL INC | Hardy Alexander | Chief Executive Officer, Director | Grant | $5.3M |
| Dec 2 | BMRN BIOMARIN PHARMACEUTICAL INC | Hardy Alexander | Chief Executive Officer, Director | Grant | $20.3K |
3 filings